Yanting Shi

1.0k total citations
34 papers, 761 citations indexed

About

Yanting Shi is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Yanting Shi has authored 34 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Yanting Shi's work include Microscopic Colitis (6 papers), Inflammatory Bowel Disease (6 papers) and RNA modifications and cancer (4 papers). Yanting Shi is often cited by papers focused on Microscopic Colitis (6 papers), Inflammatory Bowel Disease (6 papers) and RNA modifications and cancer (4 papers). Yanting Shi collaborates with scholars based in China, United States and Singapore. Yanting Shi's co-authors include Genwen Chen, Jianyong Sun, Mengmeng Liu, Yu Zhang, Jie Liang, Nan Wu, Mingzuo Jiang, Song Su, Xiaoliang Gao and Yongzhan Nie and has published in prestigious journals such as PLoS ONE, Chemical Communications and Scientific Reports.

In The Last Decade

Yanting Shi

29 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanting Shi China 11 563 452 95 63 61 34 761
Jiang Shi China 14 619 1.1× 446 1.0× 69 0.7× 75 1.2× 50 0.8× 25 753
Kai Fan China 14 557 1.0× 437 1.0× 64 0.7× 51 0.8× 59 1.0× 24 797
Xiaode Feng China 12 642 1.1× 478 1.1× 114 1.2× 104 1.7× 47 0.8× 17 851
Shunjie Xia China 9 534 0.9× 399 0.9× 98 1.0× 86 1.4× 50 0.8× 13 731
Jinfeng Ning China 13 559 1.0× 313 0.7× 135 1.4× 121 1.9× 67 1.1× 22 724
Haibiao Xie China 15 723 1.3× 504 1.1× 148 1.6× 110 1.7× 68 1.1× 30 904
Guo-Sheng Hu China 14 613 1.1× 345 0.8× 72 0.8× 124 2.0× 71 1.2× 38 824
Yongchun Yu China 12 515 0.9× 387 0.9× 140 1.5× 86 1.4× 56 0.9× 18 721
Francesco Ciccarese Italy 13 436 0.8× 260 0.6× 98 1.0× 117 1.9× 51 0.8× 17 694
Huafu Li China 10 401 0.7× 252 0.6× 104 1.1× 110 1.7× 56 0.9× 18 595

Countries citing papers authored by Yanting Shi

Since Specialization
Citations

This map shows the geographic impact of Yanting Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanting Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanting Shi more than expected).

Fields of papers citing papers by Yanting Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanting Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanting Shi. The network helps show where Yanting Shi may publish in the future.

Co-authorship network of co-authors of Yanting Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yanting Shi. A scholar is included among the top collaborators of Yanting Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanting Shi. Yanting Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Jindan, Xiaoning Liu, Zhenzhen Fan, et al.. (2025). Dual-targeted therapy for the management of refractory Crohn’s disease: a retrospective cohort study. Clinical and Experimental Medicine. 25(1). 257–257. 1 indexed citations
2.
Zhang, Yujie, et al.. (2025). Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn’s disease. Scientific Reports. 15(1). 1984–1984.
3.
Li, Siyu, Jiawen Wang, Ying Chen, et al.. (2025). Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice. Inflammation. 48(5). 3180–3193. 4 indexed citations
4.
5.
Zhang, Jiaqi, Ling Chen, Fang Wang, et al.. (2024). Effectiveness and safety of upadacitinib in acute severe ulcerative colitis patients from single Chinese IBD Center: a monocentric study. Clinical and Experimental Medicine. 24(1). 233–233. 3 indexed citations
6.
Shi, Yanting, Wuhua Jiang, Xiaoqiang Ding, et al.. (2024). Early goal-directed renal replacement therapy in severe pneumonia associated acute kidney injury. Renal Failure. 46(2). 2392844–2392844.
7.
Lv, Bing, et al.. (2023). Diagnostic value of deep learning-assisted endoscopic ultrasound for pancreatic tumors: a systematic review and meta-analysis. Frontiers in Oncology. 13. 1191008–1191008. 4 indexed citations
8.
Shi, Lizhen, et al.. (2023). Utilizing AI models to optimize blended teaching effectiveness in college-level English education. Cogent Education. 10(2). 15 indexed citations
9.
Shi, Yanting, M. Shahnawaz Khan, Mengge Zhang, et al.. (2023). Metal–organic framework-derived photoelectrochemical sensors: structural design and biosensing technology. Journal of Materials Chemistry C. 11(11). 3692–3709. 38 indexed citations
10.
Li, Xiaofei, et al.. (2023). Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study. Frontiers in Pharmacology. 14. 1259183–1259183. 2 indexed citations
11.
12.
Shi, Yanting, et al.. (2023). Deep learning-assisted diagnosis of chronic atrophic gastritis in endoscopy. Frontiers in Oncology. 13. 1122247–1122247. 6 indexed citations
13.
14.
15.
Han, Yuying, Xiaoliang Gao, Nan Wu, et al.. (2022). Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Cell Death and Disease. 13(8). 742–742. 54 indexed citations
16.
Shi, Yanting, et al.. (2022). Autophagy deficiency promotes lung metastasis of prostate cancer via stabilization of TWIST1. Clinical & Translational Oncology. 24(7). 1403–1412. 11 indexed citations
17.
Chu, Yi, Mingzuo Jiang, Nan Wu, et al.. (2020). O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation. Theranostics. 10(21). 9830–9842. 49 indexed citations
18.
Jiang, Mingzuo, Nan Wu, Bing Xu, et al.. (2019). Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis. Theranostics. 9(18). 5359–5373. 120 indexed citations
19.
Chen, Genwen, Yanting Shi, Mengmeng Liu, & Jianyong Sun. (2018). circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma. Cell Death and Disease. 9(2). 175–175. 242 indexed citations
20.
Chen, Genwen, Yanting Shi, Yu Zhang, & Jianyong Sun. (2017). CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway. OncoTargets and Therapy. Volume 10. 5783–5794. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang Shi Breakdown of academic impact, for papers by Kai Fan Breakdown of academic impact, for papers by Xiaode Feng Breakdown of academic impact, for papers by Shunjie Xia Breakdown of academic impact, for papers by Jinfeng Ning Breakdown of academic impact, for papers by Haibiao Xie Breakdown of academic impact, for papers by Guo-Sheng Hu Breakdown of academic impact, for papers by Yongchun Yu Breakdown of academic impact, for papers by Francesco Ciccarese Breakdown of academic impact, for papers by Huafu Li
Rankless by CCL
2026